About Pushkar Pharmaceuticals Pvt Ltd
Data last updated: 13 March 2026
Pushkar Pharmaceuticals Pvt Ltd is a private limited company based in U T, Chandigarh, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 03 March 1993, the company has been in operation for over 33 years.
Registered with ROC Chandigarh under CIN U24231CH1993PTC013103.
Capital: an authorised share capital of ₹24.55 Lakh and a paid-up capital of ₹14.77 Lakh. It is led by directors Neel Kamal Sharma and Chander Sheikher Pushkarna.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: # 3175Sector 45 D Chandigarh, U T, Chandigarh, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹63,000, a growth of 23% compared to the previous year.
The company is associated with 1 brand - Pushkar Pharma. As per MCA filings, the company has open charges of ₹95.75 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website pushkarpharma.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered Address# 3175Sector 45 D Chandigarh, U T, Chandigarh, India
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Pushkar Pharmaceuticals Pvt Ltd
Pushkar Pharmaceuticals Pvt Ltd operates one associated brand: Pushkar Pharma. These brands represent Pushkar Pharmaceuticals Pvt Ltd's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing of injections and formulations in Himachal Pradesh, India. | pushkarpharma.com |
Auditor Details of Pushkar Pharmaceuticals Pvt Ltd
Pushkar Pharmaceuticals Pvt Ltd is audited by O P MONGIA & ASSOCIATES for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| O P MONGIA & ASSOCIATES | blur-value | blur-value | blur-value |
Board of Directors of Pushkar Pharmaceuticals Pvt Ltd
Pushkar Pharmaceuticals Pvt Ltd is governed by 2 directors who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Neel Kamal Sharma
Also directs:
Watts Pharmaceuticals Private Limited
|
Director | 03 Mar 1993 | 33 Years 4 Months | Current |
|
Chander Sheikher Pushkarna
Also directs:
Kala- Amb Infrastructure Development Company
|
Director | 03 Mar 1993 | 33 Years 4 Months | Current |
Financials of Pushkar Pharmaceuticals Pvt Ltd FY 2025 filings available
Pushkar Pharmaceuticals Pvt Ltd reported revenue of ₹63,000 (up 23% YoY) for FY 2024. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Pushkar Pharmaceuticals Pvt Ltd
As of FY 2021, Pushkar Pharmaceuticals Pvt Ltd's shareholding pattern shows 35.21% by promoters, 64.79% by public shareholders. Public shareholders hold the majority stake, reflecting broad public ownership.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Pushkar Pharmaceuticals Pvt Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jun 1996 | Canara Bank | ₹58.25 Lakh | Open |
| 18 Apr 1996 | The Haryana Financial Corp. | ₹10.75 Lakh | Open |
| 31 Mar 1995 | Canara Bank | ₹8 Lakh | Open |
| 31 Mar 1995 | Canara Bank | ₹8 Lakh | Open |
| 18 Apr 1994 | The Haryana Financial Corp. | ₹10.75 Lakh | Open |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Pushkar Pharmaceuticals Pvt Ltd
View historical data on people associated with Pushkar Pharmaceuticals Pvt Ltd, including employment history and EPFO contributions.
Employee Count & EPFO Data of Pushkar Pharmaceuticals Pvt Ltd
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Pushkar Pharmaceuticals Pvt Ltd
GSTIN & GST Filing Data of Pushkar Pharmaceuticals Pvt Ltd
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Pushkar Pharmaceuticals Pvt Ltd
Credit Ratings, Legal Cases & Regulatory Alerts of Pushkar Pharmaceuticals Pvt Ltd
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Pushkar Pharmaceuticals Pvt Ltd
MSME Payment Delays by Pushkar Pharmaceuticals Pvt Ltd
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Pushkar Pharmaceuticals Pvt Ltd
Subsidiaries & Group Companies of Pushkar Pharmaceuticals Pvt Ltd
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Pushkar Pharmaceuticals Pvt Ltd with ownership details.
MCA Filings & Documents of Pushkar Pharmaceuticals Pvt Ltd
MCA Filings & Documents of Pushkar Pharmaceuticals Pvt Ltd
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Pushkar Pharmaceuticals Pvt Ltd
Frequently Asked Questions about Pushkar Pharmaceuticals Pvt Ltd
Pushkar Pharmaceuticals Pvt Ltd is an active private limited company in the pharma sector based in U T, Chandigarh, India. It was incorporated on 03 March 1993 (33+ years old) and is registered under CIN U24231CH1993PTC013103.
Pushkar Pharmaceuticals Pvt Ltd reported revenue of ₹63,000 for FY 2024 (up 23.00% YoY).
The current directors of Pushkar Pharmaceuticals Pvt Ltd are:
The primary industry of Pushkar Pharmaceuticals Pvt Ltd is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Pushkar Pharmaceuticals Pvt Ltd can be reached at the registered office: # 3175Sector 45 D Chandigarh, U T, Chandigarh, India, or through the website pushkarpharma.com.
The authorised capital is ₹24.55 Lakh, and the paid-up capital is ₹14.77 Lakh.